Answers are grounded in this paper and cite their sources.
This review examines pharmacologic agents addressing complications of traumatic brain injury in children, indicating a need for further research.
Children with severe traumatic brain injury (TBI) experience medical complications including paroxysmal sympathetic hyperactivity, disorders of consciousness, mood disruption, agitation, and upper motor neuron syndrome. This review article examines the pharmacologic agents used in management of complications of pediatric TBI and the evidence supporting the use of these medications. Much of the literature to support medications used in pediatric TBI comes from adult literature; therefore, more research is needed to examine the impact of these agents in pediatric patients.
No takes yet. Share an insight, caveat, or question.
Black et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: